Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Study Name
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
ClinicalTrials.gov Identifier (if applicable)
NCT04579380
Clinical Trial Category (check all that apply)
  • Beyond First Line Therapy
Study Center
Institution Name
clinicaltrials.gov for full site list
Country
United States
OVERVIEW – in layman’s terms (150 words max)
This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual. The solid tumors studied in this trial have either spread to other parts of the body or cannot be removed completely with surgery.
The trial will also look at what side effects happen
Enrollment
ongoing
Study Start Date
01/11/2021
Estimated Completion Date
05/31/2025